NCT06669507 The Sleep Clinic Outcome and Practice Study
| NCT ID | NCT06669507 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Olavs Hospital |
| Condition | Insomnia Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,400 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,400 participants in total. It began in 2025-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to explore the outcome and practice treatment for sleep-wake disturbances in a Sleep Clinic. The main questions it aims to answer are: * What is the practice (timing and duration of treatment components) of sleep-wake disturbance treatment? * What is the treatment effect of sleep-wake disturbance treatment. Participants will receive treatment as usual by consultations with a trained psychiatrist or psychologist and will be asked to fill out self-reporting questionnaires and sleep diaries.
Eligibility Criteria
Inclusion Criteria: * Referred to the Sleep Clinic at St. Olavs Hospital for an assessment of a sleep-wake disruption. * Age \>= 18 years. * Willing and able to provide written informed consent. * Meeting the diagnostic criteria for at least one of the following disorders: F51.0 Insomnia disorder or G47.2 Sleep-wake rhythm disorders, considered being either: Delayed sleep-wake phase disorder, Advanced sleep-wake phase disorder, Non-24-hour sleep-wake disorder or Irregular sleep-wake disorder * Desire non-pharmacological sleep treatment Exclusion Criteria: * Individuals working night shifts or that otherwise have external conditions that result in inadequate sleep opportunity, such as caring for an infant or does not have permanent housing etc. * Individuals being blind * Individuals being psychotic * Individuals having epilepsy * Individuals having an ongoing substance abuse
Contact & Investigator
Knut Langsrud, PhD/MD
STUDY DIRECTOR
St. Olavs Hospital
Frequently Asked Questions
Who can join the NCT06669507 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Insomnia Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06669507 currently recruiting?
Yes, NCT06669507 is actively recruiting participants. Contact the research team at knut.langsrud@stolav.no for enrollment information.
Where is the NCT06669507 trial being conducted?
This trial is being conducted at Trondheim, Norway.
Who is sponsoring the NCT06669507 clinical trial?
NCT06669507 is sponsored by St. Olavs Hospital. The principal investigator is Knut Langsrud, PhD/MD at St. Olavs Hospital. The trial plans to enroll 3,400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.